Molecular crosstalk in perivascular adipose tissue: mechanisms of inflammation, metabolic dysregulation, and therapeutic opportunities in cardiovascular disease
- PMID: 40642747
- PMCID: PMC12241021
- DOI: 10.3389/fcvm.2025.1613900
Molecular crosstalk in perivascular adipose tissue: mechanisms of inflammation, metabolic dysregulation, and therapeutic opportunities in cardiovascular disease
Abstract
The escalating recognition of perivascular adipose tissue (PVAT) as a molecular nexus in cardiovascular disease (CVD) pathogenesis necessitates a comprehensive synthesis of its spatiotemporal dynamics and therapeutic potential. This review synthesizes PVAT's roles in vascular inflammation, metabolic dysregulation, and emerging diagnostic strategies, emphasizing molecular cross-talk and spatial heterogeneity. We explore PVAT's molecular interactions in obesity, diabetes, and hypertension, elucidating its contribution to inflammation, oxidative stress, and endothelial dysfunction. Advanced imaging techniques, notably the perivascular fat attenuation index (FAI) and circulating biomarkers, are highlighted for early CVD detection. Novel therapeutic strategies, including lifestyle modifications, pharmacological interventions, and gut microbiota modulation, are discussed. Finally, we emphasize multi-omics approaches and propose a roadmap bridging basic and clinical research to advance PVAT-based CVD management.
Keywords: atherosclerosis; biomarkers; cardiovascular disease; perivascular adipose tissue; vascular inflammation.
© 2025 Zhang, Jiang, Luo, Liu, Hu, Wan, Luo, Li, Li, da Graça Espírito Santo Vasconcelos, Lavres Ceita de Carvalho, Lima Bragança da Costa, Takounjou, Maimite Das Neves, dos Ramos da Conceição, da Costa Encarnação and Zhao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Relationship Between Perivascular Adipose Tissue and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.Metab Syndr Relat Disord. 2024 Feb;22(1):1-14. doi: 10.1089/met.2023.0097. Epub 2023 Oct 25. Metab Syndr Relat Disord. 2024. PMID: 37878791
-
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.World J Cardiol. 2025 Jun 26;17(6):106147. doi: 10.4330/wjc.v17.i6.106147. World J Cardiol. 2025. PMID: 40575425 Free PMC article. Review.
-
Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.Microvasc Res. 2024 Jan;151:104601. doi: 10.1016/j.mvr.2023.104601. Epub 2023 Sep 9. Microvasc Res. 2024. PMID: 37690507
-
Comprehensive bioinformatics analysis of the common mechanism of atherosclerosis and atrial fibrillation: emphasizing mitochondrial metabolic disorder and immune inflammation.Front Mol Biosci. 2025 Jun 18;12:1595048. doi: 10.3389/fmolb.2025.1595048. eCollection 2025. Front Mol Biosci. 2025. PMID: 40607061 Free PMC article.
-
Integrated multi-omics analysis reveals the functional signature of microbes and metabolomics in pre-diabetes individuals.Microbiol Spectr. 2025 Jul;13(7):e0145924. doi: 10.1128/spectrum.01459-24. Epub 2025 Jun 9. Microbiol Spectr. 2025. PMID: 40488467 Free PMC article.
References
-
- Meijer RI, Hoevenaars FPM, Serné EH, Yudkin JS, Kokhuis TJA, Weijers EM, et al. JNK2 in myeloid cells impairs insulin’s vasodilator effects in muscle during early obesity development through perivascular adipose tissue dysfunction. Am J Physiol Heart Circ Physiol. (2019) 317(2):H364–74. 10.1152/ajpheart.00663.2018 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources